PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
Visit https://www.peervoice.com/FEW860 to view the entire programme with slides. After completing “Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?”, participants will be able to: Explain the rationale for the current focus on slowing the progression of chronic kidney disease (CKD) in patients with type 2 diabetes (T2DM); Evaluate the use of GLP-1 RAs as part of a for multifactorial management plan for patients with T2DM and CKD; Formulate treatment plans incorporating current guideline recommendations to slow the progression of CKD in patients with T2DM.